| P2093 | author name string | Cynthia L Harden | |
| P2860 | cites work | Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism | Q34287561 |
| | On the association between valproate and polycystic ovary syndrome | Q34301379 |
| | On the association between valproate and polycystic ovary syndrome: a response and an alternative view | Q34301384 |
| | The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence | Q34317530 |
| | The prevalence and features of the polycystic ovary syndrome in an unselected population | Q34325018 |
| | Polycystic ovarian syndrome in women with epilepsy: a review | Q34345051 |
| | Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome | Q34349973 |
| | Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women | Q34489447 |
| | Polycystic ovaries--a common finding in normal women | Q34560172 |
| | Seizure frequency is associated with age at menopause in women with epilepsy | Q35206273 |
| | The neuroendocrine control of the menstrual cycle. | Q40258390 |
| | Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone | Q41779485 |
| | Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells | Q42445303 |
| | Valproate potentiates androgen biosynthesis in human ovarian theca cells | Q42451796 |
| | Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy | Q42602749 |
| | Valproate, but not lamotrigine, induces ovarian morphological changes in Wistar rats | Q43546464 |
| | Valproate and the polycystic ovarian syndrome: final thoughts | Q43665509 |
| | Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy | Q43735961 |
| | Predictors of ovulatory failure in women with epilepsy | Q44226796 |
| | Endocrine and metabolic responses to long-term monotherapy with the antiepileptic drug valproate in the normally cycling rhesus monkey | Q44467122 |
| | Long-term reproductive endocrine health in young women with epilepsy during puberty. | Q44761919 |
| | Aromatase inhibition, testosterone, and seizures. | Q44880545 |
| | Reproductive endocrine disorders in women with partial seizures of temporal lobe origin | Q48363627 |
| | Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy | Q48575295 |
| | Obesity and endocrine disorders in women taking valproate for epilepsy. | Q51034614 |
| | Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. | Q51563371 |
| | Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy | Q70513355 |
| | A relationship between particular reproductive endocrine disorders and the laterality of epileptiform discharges in women with epilepsy | Q70514541 |
| | Altered pulsatile secretion of luteinizing hormone in women with epilepsy | Q72776678 |
| | Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women | Q74163690 |
| | Ultrasound diagnosis of polycystic ovaries in women who have no symptoms of polycystic ovary syndrome is not associated with subfecundity or subfertility | Q79160358 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | polycystic ovary syndrome | Q500816 |
| | polycystic ovary | Q5547896 |
| P304 | page(s) | 142-6 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Epilepsy Currents | Q5382972 |
| P1476 | title | Polycystic ovaries and polycystic ovary syndrome in epilepsy: evidence for neurogonadal disease | |
| P478 | volume | 5 | |